Mercer Global Advisors
HZNP

Mercer Global Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Mercer Global Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,410
Closed -$1.44M – 2132
2023
Q3 		$1.44M Buy
12,410
+895
+8% +$96.2K 0.01% 805
2023
Q2 		$1.18M Buy
11,515
+7,613
+195% +$803K ﹤0.01% 890
2023
Q1 		$426K Buy
3,902
+1,397
+56% +$154K ﹤0.01% 1291
2022
Q4 		$285K Buy
+2,505
New +$208K ﹤0.01% 1528
2022
Q3 		– Sell
-2,565
Closed -$205K – 1948
2022
Q2 		$205K Sell
2,565
-543
-17% -$51.4K ﹤0.01% 1627
2022
Q1 		$327K Buy
+3,108
New +$303K ﹤0.01% 1467
2021
Q4 		– Sell
-2,204
Closed -$241K – 1885
2021
Q3 		$241K Sell
2,204
-276
-11% -$28.7K ﹤0.01% 1524
2021
Q2 		$232K Sell
2,480
-2,806
-53% -$258K ﹤0.01% 1500
2021
Q1 		$487K Buy
5,286
+1,539
+41% +$130K ﹤0.01% 1090
2020
Q4 		$274K Buy
+3,747
New +$279K ﹤0.01% 1103

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mercer Global Advisors's HZNP Position: Q4 2023 in Review

Mercer Global Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 12,410 shares — an estimated $1.44M sold.

Mercer Global Advisors first reported a position in HZNP in Q4 2020 and held it in 10 quarters. The position peaked at $1.44M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Mercer Global Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Mercer Global Advisors sold 12,410 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.44M.
  • Mercer Global Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 10 quarters.
  • Mercer Global Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.44M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Mercer Global Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.